A meta-analysis of immunosuppression withdrawal trials in renal transplantation

Journal of the American Society of Nephrology

Volumn 11, Issue 10, 2000, Pages 1910-1917

  Kasiske, Bertram L ^a,d   Chakkera, Harini A ^b   Louis, Thomas A ^b   Ma, Jennie Z ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; PREDNISONE;

ARTICLE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG WITHDRAWAL; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; META ANALYSIS; PEER REVIEW; PRIORITY JOURNAL; PUBLICATION;

EID: 0033774719     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hricik DE, O'Toole MA, Schulak JA, Herson J: Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: A meta-analysis. J Am Soc Nephrol 4: 1300-1305, 1993
2. Lebranchu Y, for the M 55002 Study Group: Comparison of two corticosteroid regimens in combination with CellCept and Cyclosporine A for prevention of acute allograft rejection: 12 month results of a double-blind, randomized, multi-center study. Transplant Proc 31: 249-250, 1999
3. Ahsan N, Hricik D, Matas A, Rose S, Tomlanovich S, Wilkinson A, Ewell M, McIntosh M, Stablein D, Hodge E: Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil: A prospective randomized study. Transplantation 68: 1865-1874, 1999
4. Kasiske BL, Heim-Duthoy K, Ma JZ: Elective cyclosporine withdrawal after renal transplantation: A meta-analysis. JAMA 269: 395-400, 1993
5. Isoniemi H, Ahonen J, Eklund B, Höckerstedt K, Salmela K, von Willebrand E, Häyry P: Renal allograft immunosuppression. Transpl Int 3: 121-127, 1990
6. Isoniemi H: Renal allograft immunosuppression III: Triple therapy versus three different combinations of double drug treatment-Two year results in kidney transplant patients. Transpl Int 4: 31-37, 1991
7. Isoniemi HM, Ahonen J, Tikkanen MJ, van Willebrand EO, Krogerus L, Eklund BH, Höckerstedt KV, Salmela KE, Hayry PJ: Long-term consequences of different immunosuppressive regimens for renal allografts. Transplantation (Baltim) 55: 494499, 1993
8. Cristinelli L, Brunori G, Setti G, Manganoni A, Manganoni AM, Scolari F, Sandrini S, Scaini PS, Savoldi S, Camerini C, Maiorca R: Withdrawal of methylprednisolone at the sixth month in renal transplant recipients treated with cyclosporine. Transplant Proc 19: 2021-2023, 1987
9. Maiorca R, Cristinelli L, Brunori G, Setti G, Salerni B, De Nobili U, Mittempergher F: Prospective controlled trial of steroid withdrawal after six months in renal transplant patients treated with cyclosporine. Transplant Proc 20: 121-125, 1988
10. Schulak JA, Mayes JT, Moritz CE, Hricik DE: A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients. Transplantation 49: 327-332, 1990
11. Hricik DE, Walen CC, Lautman J, Bartucci MR, Moir EJ, Mayes JT, Schulak JA: Withdrawal of steroids after renal transplantation: Clinical predictors of outcome. Transplantation (Baltim) 53: 41-45, 1992
12. Hollander A A, Hene RJ, Hermans J, Van Es LA, van der Woude FJ: Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: A randomized study. J Am Soc Nephrol 8: 294-301, 1997
13. Gulanikar AC, Belitsky P, MacDonald AS, Cohen A, Bitter-Seurmann H: Randomized controlled trial of steroids versus no steroids in stable cyclosporine-treated renal graft recipients. Transplant Proc 23: 990-991, 1991
14. Ratcliffe PJ, Dudley CR, Higgins RM, Firth JD, Smith B, Morris PJ: Randomized controlled trial of complete steroid withdrawal in renal transplant patients receiving triple immunosuppression. Transplant Proc 25: 590, 1993
15. Ratcliffe PJ, Dudley CR, Higgins RM, Firth JD, Smith B, Morris PJ: Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 348: 643-648, 1996
16. Ponticelli C, Tarantino A, Segoloni GP, Cambi V, Rizzo G, Altieri P, Mastrangelo F, Castagneto M, Salvadori M, Valente U, Cossu M, Federico S, Pisani F, Monagnino G, Messina M, Arisi L, Carmellini M, Piredda G, Corbetta G, for the Italian Multicentre Study Group for Renal Transplantation: A randomized study comparing cyclosporine alone vs double and triple therapy in renal transplants. Transplant Proc 29: 290-291, 1997
17. Ponticelli C, Tarantino A, Segoloni GP, Cambi V, Rizzo G, Altieri P, Mastrangelo F, Castagneto M, Salvadori M, Valente U, Cossu M, Federico S, Pisani F, Monagnino G, Messina M, Arisi L, Carmellini M, Piredda G, Corbetta G, for the Italian Multicentre Study Group for Renal Transplantation: A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation. J Am Soc Nephrol 8: 638-646, 1997
18. Sinclair NR: Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts: The Canadian Multicentre Transplant Study Group. CMAJ 147: 645-657, 1992
19. Land W, Castro LA, Hillebrand G, Günther K, Gokel JM: Conversion rejection consequences by changing the immunosuppressive therapy from cyclosporine to azathioprine after kidney transplantation. Transplant Proc 15: 2857-2861, 1983
20. Sagalowsky AI, Reisman ME, Dawidson I, Toto R, Peters PC, Helderman JH: Late cyclosporine conversion carried risk of irreversible rejection. Transplant Proc 20: 157-160, 1988